Literature DB >> 23908254

Sarcoma chemotherapy.

Brian E Walczak1, Ronald B Irwin.   

Abstract

Sarcomas are a rare, heterogeneous group of malignant tumors of the bone or soft tissue. Although historically intended for the pharmaceutical treatment of microbes, today chemotherapy is used in orthopaedic oncology and is arguably the primary reason for improved survivorship. Agents such as anthracyclines (eg, doxorubicin), alkylating agents (eg, cyclophosphamide, ifosfamide), antimetabolites (eg, methotrexate), topoisomerase inhibitors (eg, etoposide [VP-16]), vinca alkaloids (eg, vincristine), and cytotoxic antibiotics (eg, actinomycin D) are used in various combinations to manage different types of tumors. Side effects are common and range from mild to severe. The effectiveness of the chemotherapy regimen correlates with the extent of tumor necrosis.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23908254     DOI: 10.5435/JAAOS-21-08-480

Source DB:  PubMed          Journal:  J Am Acad Orthop Surg        ISSN: 1067-151X            Impact factor:   3.020


  7 in total

1.  Feasibility and clinical value of CT-guided 125I brachytherapy for metastatic soft tissue sarcoma after first-line chemotherapy failure.

Authors:  Zhiqiang Mo; Tao Zhang; Yanling Zhang; Zhanwang Xiang; Huzhen Yan; Zhihui Zhong; Fei Gao; Fujun Zhang
Journal:  Eur Radiol       Date:  2017-09-27       Impact factor: 5.315

2.  Recurrent pulmonary synovial sarcoma effectively treated with amrubicin: A case report.

Authors:  Hiroaki Satoh; Norio Takayashiki; Toshihiro Shiozawa; Kunihiko Miyazaki; Gen Ohara; Katsunori Kagohashi; Koichi Kurishima; Shintaro Sugita; Tomoyuki Aoyama; Tadashi Hasegawa; Nobuyuki Hizawa
Journal:  Exp Ther Med       Date:  2015-02-24       Impact factor: 2.447

3.  Distal ulna leiomyosarcoma treated with custom polymethylmethacrylate prosthesis with a 4-year follow-up.

Authors:  Jose Arturo Pacheco-Nuñez; Joseph E Sheppard; Andrew P Mahoney
Journal:  Hand (N Y)       Date:  2015-09

4.  Evaluating Soft-Tissue Lumps and Bumps.

Authors:  Dane J Church; John Krumme; Suhel Kotwal
Journal:  Mo Med       Date:  2017 Jul-Aug

5.  The β-adrenergic receptor antagonist propranolol offsets resistance mechanisms to chemotherapeutics in diverse sarcoma subtypes: a pilot study.

Authors:  Letizia Porcelli; Marianna Garofoli; Roberta Di Fonte; Livia Fucci; Mariateresa Volpicella; Sabino Strippoli; Michele Guida; Amalia Azzariti
Journal:  Sci Rep       Date:  2020-06-26       Impact factor: 4.379

6.  In Vivo Bioorthogonal Chemistry Enables Local Hydrogel and Systemic Pro-Drug To Treat Soft Tissue Sarcoma.

Authors:  Jose M Mejia Oneto; Irfan Khan; Leah Seebald; Maksim Royzen
Journal:  ACS Cent Sci       Date:  2016-07-13       Impact factor: 14.553

7.  Histone deacetylase inhibitor ITF2357 leads to apoptosis and enhances doxorubicin cytotoxicity in preclinical models of human sarcoma.

Authors:  Marta Di Martile; Marianna Desideri; Maria Grazia Tupone; Simonetta Buglioni; Barbara Antoniani; Carlotta Mastroiorio; Rita Falcioni; Virginia Ferraresi; Nicola Baldini; Roberto Biagini; Michele Milella; Daniela Trisciuoglio; Donatella Del Bufalo
Journal:  Oncogenesis       Date:  2018-02-23       Impact factor: 7.485

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.